1. kingsnymptonps
2. ghueck
3. ccaseyrn7
4. jadeone11
5. benjimichigan
1.ccaseyrn7 01/25/2018
They get cash to work on their other targets
2.kingsnymptonps 01/25/2018
Heading North.
3.ghueck 03/15/2018
Misses EPS loss estimates by $0.15. Beats on revenues.
4.ccaseyrn7 01/25/2018
ah huh.
5.jadeone11 01/26/2018
Any problems here?
6.gojeck 01/25/2018
Awesome news!
7.jadeone11 08/07/2018
Beats EPS loss estimates by $0.21 and beats on revenues
8.kingsnymptonps 01/25/2018
$KPTI NEWS! Big money!
9.ghueck 01/26/2018
Been 2 good days now an offering
10.benjimichigan 05/24/2018
Karyopharm and Antengene Sign Exclusive License Agreement to Develop and Commercialize Selinexor, Eltanexor, Verdinexor and KPT-9274 in China and Other Regions in Asia
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW